TUESDAY, Nov. 10, 2026 The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that
Rare Eye Condition Prompts New FDA Warning On Popular GLP-1 Drugs
Latest from Blog
The U.S. may soon lose measles elimination status
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. We’re working today here at STAT. Send story ideas (I’m still on
Getting Your Kids To A Park Or Playground May Change Their Future
WEDNESDAY, Nov. 11, 2026 Taking your kids to the playground does more than get them some fresh air and a good night s sleep.British researchers report that chil Post Views: 0
Why Early-Onset Alzheimer’s Is More Aggressive
WEDNESDAY, Nov. 11, 2026 A signature protein in Alzheimer s disease builds up much faster and spreads more widely in the brain in people with early-onset Alzhei Post Views: 0
STAT+: Doctors on Kennedy’s influential preventive care panel have major conflicts of interest, filings reveal
WASHINGTON — Federal officials have granted blanket waivers to every member of an influential, yet little-known federal panel that evaluates preventive medical services, allowing them to serve despite some having clear financial
Aurobindo unit Eugia recalls antibiotic lot, citing glass particle concerns
Eugia, a unit of Aurobindo, issued a voluntary recall for one lot of the antibiotic vancomycin hydrochloride for injection, citing the possible presence of glass particles in the vials. Post Views: 0